Market Research on Febrile Neutropenia Market 2014 and Analysis to 2020
Febrile neutropenia is defined as the development of fever with the sign of infection. Febrile neutropenia is one of the most severe complications of cancer chemotherapy and is mainly caused by infectious agents like gram-positive and gram-negative bacteria. This diseased condition significantly reduces white blood cell count of the patients. A blood test is helpful to determine the number of white blood cells and to diagnose febrile neutropenia disease. Additionally, a patient with febrile neutropenia is treated with prophylactic antibiotics...
View full press release